• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猫眼中的垂体腺苷酸环化酶激活肽免疫反应性神经纤维。

Pituitary adenylate cyclase-activating peptide-immunoreactive nerve fibers in the cat eye.

作者信息

Elsås T, Uddman R, Sundler F

机构信息

Department of Ophthalmology, University Hospital of Trondheim, Norway.

出版信息

Graefes Arch Clin Exp Ophthalmol. 1996 Sep;234(9):573-80. doi: 10.1007/BF00448802.

DOI:10.1007/BF00448802
PMID:8880156
Abstract

PURPOSE

To study the occurrence and distribution of the neuropeptide pituitary adenylate cyclase-activating peptide (PACAP) in ocular and orbital structures of the cat.

METHODS

Immunocyto-chemistry to localize PACAP and double immunostaining to detect co-localization of PACAP with other neuropeptides.

RESULTS

Numerous PACAP-immunoreactive nerve fibers were observed in the lacrimal gland, choroid and retroocular arteries. There was a sparse supply of PACAP-containing nerve fibers in the iris, ciliary body and conjunctiva. Subpopulations of PACAP-containing nerve fibers stored vasoactive intestinal peptide (VIP) or calcitonin gene-related peptide (CGRP). Around 10% of the ganglion cells in the sphenopalatine ganglion harbored PACAP immunoreactivity. In the trigeminal ganglion around 5% of the neuronal cell bodies and in the ciliary ganglion only occasional ganglion cells contained PACAP immunoreactivity. PACAP immunoreactivity co-localized with VIP in the sphenopalatine ganglion and with CGRP in the trigeminal ganglion.

CONCLUSION

PACAP-containing nerves in the eye and associated structures demonstrate a distribution pattern resembling that of VIP. Subpopulations of nerve fibers containing PACAP immunoreactivity store VIP or CGRP immunoreactivity. Neuronal PACAP in the eye and orbit may take part in regulation of smooth muscle tone, glandular secretion and sensory processing.

摘要

目的

研究神经肽垂体腺苷酸环化酶激活肽(PACAP)在猫眼和眼眶结构中的发生及分布情况。

方法

采用免疫细胞化学方法定位PACAP,并通过双重免疫染色检测PACAP与其他神经肽的共定位情况。

结果

在泪腺、脉络膜和眼后动脉中观察到大量PACAP免疫反应性神经纤维。虹膜、睫状体和结膜中含PACAP的神经纤维供应稀少。含PACAP的神经纤维亚群储存血管活性肠肽(VIP)或降钙素基因相关肽(CGRP)。蝶腭神经节中约10%的神经节细胞具有PACAP免疫反应性。在三叉神经节中,约5%的神经元细胞体以及在睫状神经节中仅有偶尔的神经节细胞含有PACAP免疫反应性。PACAP免疫反应性在蝶腭神经节中与VIP共定位,在三叉神经节中与CGRP共定位。

结论

眼及相关结构中含PACAP的神经呈现出与VIP相似的分布模式。含PACAP免疫反应性的神经纤维亚群储存VIP或CGRP免疫反应性。眼和眼眶中的神经元PACAP可能参与平滑肌张力、腺体分泌和感觉处理的调节。

相似文献

1
Pituitary adenylate cyclase-activating peptide-immunoreactive nerve fibers in the cat eye.猫眼中的垂体腺苷酸环化酶激活肽免疫反应性神经纤维。
Graefes Arch Clin Exp Ophthalmol. 1996 Sep;234(9):573-80. doi: 10.1007/BF00448802.
2
Pituitary adenylate cyclase-activating polypeptide in intrinsic and extrinsic nerves of the rat pancreas.大鼠胰腺内在和外在神经中的垂体腺苷酸环化酶激活多肽
Cell Tissue Res. 2000 Jan;299(1):59-70. doi: 10.1007/s004419900124.
3
Pituitary adenylate cyclase activating polypeptide (PACAP) in the gastrointestinal tract of the rat: distribution and effects of capsaicin or denervation.大鼠胃肠道中的垂体腺苷酸环化酶激活多肽(PACAP):辣椒素或去神经支配的分布及影响
Cell Tissue Res. 1998 Jan;291(1):65-79. doi: 10.1007/s004410050980.
4
Innervation of the rat pineal gland by pituitary adenylate cyclase-activating polypeptide (PACAP)-immunoreactive nerve fibres.垂体腺苷酸环化酶激活多肽(PACAP)免疫反应性神经纤维对大鼠松果体的神经支配。
Cell Tissue Res. 1999 May;296(2):247-57. doi: 10.1007/s004410051286.
5
Pituitary adenylate cyclase-activating peptide (PACAP), a new vasoactive intestinal peptide (VIP)-like peptide in the respiratory tract.垂体腺苷酸环化酶激活肽(PACAP),一种呼吸道中新型的血管活性肠肽(VIP)样肽。
Cell Tissue Res. 1991 Jul;265(1):197-201. doi: 10.1007/BF00318155.
6
Pituitary adenylate cyclase activating polypeptide is expressed in autonomic neurons.垂体腺苷酸环化酶激活多肽在自主神经元中表达。
Regul Pept. 1995 Sep 22;59(1):121-8. doi: 10.1016/0167-0115(95)00082-m.
7
Pituitary adenylate cyclase activating polypeptide immunoreactivity in capsaicin-sensitive nerve fibres supplying the rat urinary tract.供应大鼠泌尿道的辣椒素敏感神经纤维中的垂体腺苷酸环化酶激活多肽免疫反应性
Neuroscience. 1998 Apr;83(4):1261-72. doi: 10.1016/s0306-4522(97)00474-0.
8
Distribution and effects of pituitary adenylate cyclase-activating peptide in the rabbit eye.垂体腺苷酸环化酶激活肽在兔眼中的分布及作用
Neuroscience. 1995 Nov;69(1):297-308. doi: 10.1016/0306-4522(95)00258-k.
9
Pituitary adenylate cyclase-activating polypeptide-immunoreactive nerve fibers in rat and human tooth pulps.大鼠和人类牙髓中垂体腺苷酸环化酶激活多肽免疫反应性神经纤维
Brain Res. 2003 Aug 8;980(2):288-92. doi: 10.1016/s0006-8993(03)02876-2.
10
Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut.垂体腺苷酸环化酶激活肽:一种肠道中新型的血管活性肠肽样神经肽。
Neuroscience. 1992;46(2):439-54. doi: 10.1016/0306-4522(92)90064-9.

引用本文的文献

1
Potential Therapeutic Role of Pituitary Adenylate Cyclase-Activating Polypeptide for Dry Eye Disease.垂体腺苷酸环化酶激活肽治疗干眼症的潜在作用。
Int J Mol Sci. 2022 Jan 8;23(2):664. doi: 10.3390/ijms23020664.
2
PACAP and PAC1 receptor expression in pancreatic ductal carcinoma.垂体腺苷酸环化酶激活肽及PAC1受体在胰腺导管癌中的表达
Oncol Lett. 2019 Dec;18(6):5725-5730. doi: 10.3892/ol.2019.10971. Epub 2019 Oct 8.
3
Neuroprotective Potential of Pituitary Adenylate Cyclase Activating Polypeptide in Retinal Degenerations of Metabolic Origin.

本文引用的文献

1
Pituitary adenylate cyclase activating polypeptide is expressed in autonomic neurons.垂体腺苷酸环化酶激活多肽在自主神经元中表达。
Regul Pept. 1995 Sep 22;59(1):121-8. doi: 10.1016/0167-0115(95)00082-m.
2
Distribution and effects of pituitary adenylate cyclase-activating peptide in the rabbit eye.垂体腺苷酸环化酶激活肽在兔眼中的分布及作用
Neuroscience. 1995 Nov;69(1):297-308. doi: 10.1016/0306-4522(95)00258-k.
3
PACAP, a VIP-like peptide: immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow.
垂体腺苷酸环化酶激活多肽在代谢性视网膜变性中的神经保护潜力
Front Neurosci. 2019 Oct 9;13:1031. doi: 10.3389/fnins.2019.01031. eCollection 2019.
4
Effects of PACAP on Dry Eye Symptoms, and Possible Use for Therapeutic Application.PACAP 对干眼症症状的影响,以及在治疗应用中的可能用途。
J Mol Neurosci. 2019 Jul;68(3):420-426. doi: 10.1007/s12031-018-1087-1. Epub 2018 Jun 22.
5
PACAP suppresses dry eye signs by stimulating tear secretion.PACAP 通过刺激泪液分泌来抑制干眼症状。
Nat Commun. 2016 Jun 27;7:12034. doi: 10.1038/ncomms12034.
6
Autonomic control of the eye.眼睛的自主控制。
Compr Physiol. 2015 Jan;5(1):439-73. doi: 10.1002/cphy.c140014.
7
Investigation of the effects of PACAP on the composition of tear and endolymph proteins.垂体腺苷酸环化酶激活肽对泪液和内淋巴蛋白质组成影响的研究。
J Mol Neurosci. 2008 Nov;36(1-3):321-9. doi: 10.1007/s12031-008-9067-5. Epub 2008 Apr 18.
J Cereb Blood Flow Metab. 1993 Mar;13(2):291-7. doi: 10.1038/jcbfm.1993.36.
4
Differential signal transduction by five splice variants of the PACAP receptor.垂体腺苷酸环化酶激活肽(PACAP)受体的五种剪接变体的差异信号转导
Nature. 1993 Sep 9;365(6442):170-5. doi: 10.1038/365170a0.
5
Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide.垂体腺苷酸环化酶激活多肽受体的分子克隆与组织分布
Neuron. 1993 Aug;11(2):333-42. doi: 10.1016/0896-6273(93)90188-w.
6
Type I receptors for PACAP (a neuropeptide even more important than VIP?).
Biochim Biophys Acta. 1993 Oct 29;1154(2):183-99. doi: 10.1016/0304-4157(93)90011-c.
7
Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells.在胰岛素分泌细胞中表达的第三种垂体腺苷酸环化酶激活多肽受体亚型的克隆与功能特性分析
Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2679-83. doi: 10.1073/pnas.91.7.2679.
8
PACAP is a potent and highly effective stimulator of adenylyl cyclase activity in the retinas of different mammalian species.垂体腺苷酸环化酶激活肽是不同哺乳动物视网膜中腺苷酸环化酶活性的一种强效且高效的刺激物。
Brain Res. 1994 Mar 28;641(1):132-4. doi: 10.1016/0006-8993(94)91825-2.
9
Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase.垂体腺苷酸环化酶激活多肽(PACAP)的眼部受体特性及其与腺苷酸环化酶的偶联
Exp Eye Res. 1994 Apr;58(4):459-67. doi: 10.1006/exer.1994.1039.
10
Pituitary adenylate cyclase activating peptide (PACAP) mRNA in the rat neocortex.
Neurosci Lett. 1994 Apr 25;171(1-2):121-4. doi: 10.1016/0304-3940(94)90620-3.